The Effect Of Meditation On Quality Of Life In Women With Breast Cancer And Other Gynecological Cancers
1 other identifier
interventional
94
1 country
1
Brief Summary
Women with breast cancer and other gynecologic cancers often suffer significant distress and disability from their disease. A practice of meditation-based stress reduction and cognitive-affective-behavioral learning may help women with these conditions decrease their suffering and improve their quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2003
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2003
CompletedFirst Submitted
Initial submission to the registry
November 3, 2005
CompletedFirst Posted
Study publicly available on registry
November 4, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2010
CompletedFebruary 23, 2017
February 1, 2017
6.8 years
November 3, 2005
February 17, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Quality of life will be assessed by within patient differences in the FACT-G (General Functional Assessment of Cancer Treatment Scale), as well as with the disease specific subscales at baseline and at 12 months.
Subjects will complete questionnaires at baseline and closeout. Patients will participate in the meditation program weekly for 20 weeks.
Study Arms (1)
Mindfulness based meditation program
EXPERIMENTALMeditation and Breast Cancer: Subjects will participate in an intervention consisting of group and individual instruction in a meditation-based practice of stress-reduction and cognitive-affective-behavioral learning.
Interventions
Subjects will participate in an intervention consisting of group and individual instruction in a meditation-based practice of stress-reduction and cognitive-affective-behavioral learning.
Eligibility Criteria
You may not qualify if:
- Patients who refuse to participate will be excluded
- Patients with Metastatic cancer are excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Weill Medical College of Cornell Universitylead
- Avon Foundationcollaborator
Study Sites (1)
Weill Cornell Medical College-New York Hospital
New York, New York, 10065, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mary E Charlson, MD
Weill Medical College of Cornell University
- PRINCIPAL INVESTIGATOR
Joseph Loizzo, MD,PhD
Center for Complementary and Intergrative Medicine, New York Presbyterian Hospital-Weill Cornell Medical College
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 3, 2005
First Posted
November 4, 2005
Study Start
May 1, 2003
Primary Completion
March 1, 2010
Study Completion
March 1, 2010
Last Updated
February 23, 2017
Record last verified: 2017-02
Data Sharing
- IPD Sharing
- Will not share
No Plan to Share IPD